Mario A Cepeda

Title: Innovations by Mario A. Cepeda

Introduction

Mario A. Cepeda is a notable inventor based in Winchester, MA (US). He has made significant contributions to the field of biotechnology, particularly in the development of antibodies targeting vascular endothelial growth factor (VEGF). With a total of 4 patents to his name, his work has the potential to impact therapeutic approaches for various diseases.

Latest Patents

Among his latest patents is the invention titled "Nucleic acids encoding anti-VEGF-A antibodies and uses thereof." This invention relates to antibodies that exhibit activity against VEGF, along with methods for their production and application. Another significant patent is "Nucleic acids encoding bispecific anti-VEGF and anti-ANG2 antibodies and uses thereof." This invention focuses on bispecific antibodies that target both VEGF and angiopoietin (ANG), providing innovative methods for their creation and utilization.

Career Highlights

Mario A. Cepeda is currently associated with MedImmune Limited, a prominent company in the biopharmaceutical sector. His work at MedImmune has allowed him to further his research and development efforts in creating advanced therapeutic solutions.

Collaborations

Some of his notable coworkers include Ching Ching Leow and Nazzareno Dimasi, who have collaborated with him on various projects within the company.

Conclusion

Mario A. Cepeda's contributions to the field of biotechnology through his innovative patents and collaborations highlight his role as a significant inventor. His work continues to pave the way for advancements in medical treatments.